Archer Investment Corporation’s Immunogen Inc IMGN Stock Holding History

Archer Investment Corporation’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-51	Closed	–	–	651
2019 Q3	$0	Buy	+51	New	+$135	﹤0.01%	556

Other funds holding IMGN

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Archer Investment Corporation's IMGN Position: Q4 2019 in Review

Archer Investment Corporation sold out of Immunogen Inc (IMGN) in Q4 2019, closing a stake of 51 shares.

Archer Investment Corporation first reported a position in IMGN in Q3 2019 and held it in 1 quarter. The position peaked at $0 in Q3 2019. 191 funds tracked by Wall St. Rank hold IMGN as of Q4 2019.

Archer Investment Corporation reported no remaining Immunogen Inc position as of Q4 2019 after selling out during the quarter.
Archer Investment Corporation sold 51 Immunogen Inc shares in Q4 2019.
Archer Investment Corporation first reported a position in Immunogen Inc in Q3 2019 and held it in 1 quarter.
Archer Investment Corporation's Immunogen Inc position peaked at $0 in Q3 2019.
191 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2019.

Based on Archer Investment Corporation's 13F filing for Q4 2019, filed 20 Feb 2020.